
        <!DOCTYPE html>
        <html>
        <head>
            <meta charset="UTF-8">
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <title>CASSIA Cell Type Annotation Summary</title>
            <style>
                :root {
                    --primary-color: #2563eb;
                    --secondary-color: #0891b2;
                    --accent-color: #4f46e5;
                    --light-bg: #f3f4f6;
                    --border-color: #e5e7eb;
                    --text-color: #1f2937;
                    --text-light: #6b7280;
                }
                
                body {
                    font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
                    line-height: 1.6;
                    color: var(--text-color);
                    background-color: #ffffff;
                    margin: 0;
                    padding: 0;
                }
                
                .container {
                    max-width: 900px;
                    margin: 0 auto;
                    padding: 2rem;
                }
                
                header {
                    text-align: center;
                    margin-bottom: 2.5rem;
                    border-bottom: 2px solid var(--border-color);
                    padding-bottom: 1rem;
                }
                
                h1 {
                    color: var(--primary-color);
                    font-size: 2.5rem;
                    margin-bottom: 0.5rem;
                }
                
                .subtitle {
                    color: var(--text-light);
                    font-size: 1.2rem;
                    margin-top: 0;
                }
                
                section {
                    margin-bottom: 2.5rem;
                    background-color: white;
                    border-radius: 0.5rem;
                    box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
                    padding: 1.5rem;
                    border-left: 4px solid var(--primary-color);
                }
                
                h2 {
                    color: var(--primary-color);
                    font-size: 1.8rem;
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                h3 {
                    color: var(--secondary-color);
                    font-size: 1.3rem;
                    margin: 1.5rem 0 0.5rem;
                }
                
                ul, ol {
                    padding-left: 1.5rem;
                }
                
                li {
                    margin-bottom: 0.5rem;
                }
                
                .final-annotation {
                    background-color: #ecfdf5;
                    border-left: 4px solid #10b981;
                }
                
                .final-annotation h2 {
                    color: #10b981;
                }
                
                .iteration {
                    margin-bottom: 1.5rem;
                    background-color: var(--light-bg);
                    border-radius: 0.5rem;
                    padding: 1.5rem;
                    border-left: 4px solid var(--secondary-color);
                }
                
                .iteration-title {
                    font-size: 1.5rem;
                    color: var(--secondary-color);
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                .gene-list {
                    display: flex;
                    flex-wrap: wrap;
                    gap: 0.5rem;
                    margin: 1rem 0;
                }
                
                .gene-badge {
                    background-color: var(--accent-color);
                    color: white;
                    padding: 0.3rem 0.7rem;
                    border-radius: 1rem;
                    font-size: 0.9rem;
                    font-weight: 500;
                }
                
                .sub-section {
                    background-color: white;
                    border-radius: 0.3rem;
                    padding: 1rem;
                    margin-top: 1rem;
                }
                
                code {
                    font-family: ui-monospace, monospace;
                    font-size: 0.9em;
                }
                
                .marker-category {
                    margin-bottom: 1rem;
                }
                
                .marker-category-title {
                    font-weight: 600;
                    margin-bottom: 0.5rem;
                    color: var(--secondary-color);
                }
                
                .hypothesis-list {
                    display: flex;
                    flex-direction: column;
                    gap: 0.8rem;
                }
                
                .hypothesis-item {
                    padding-left: 1.5rem;
                    position: relative;
                    margin-bottom: 0.5rem;
                }
                
                .hypothesis-number {
                    position: absolute;
                    left: 0;
                    font-weight: 600;
                    color: var(--accent-color);
                }
                
                .hypothesis-item-continued {
                    padding-left: 1.5rem;
                    margin-top: -0.3rem;
                    color: var(--text-light);
                }
            </style>
        </head>
        <body>
            <div class="container">
                <header>
                    <h1>CASSIA Cell Type Annotation Summary</h1>
                    <p class="subtitle">Single-cell RNA-seq Analysis Report</p>
                </header>
                
                <section>
                    <h2>Overview</h2>
                    <div class="content">
                        This report summarizes the iterative gene expression analysis performed by CASSIA to annotate a cell cluster from the large intestine. The analysis involved 4 iterations, examining a total of 48 unique genes.
                    </div>
                </section>
                
                <section>
                    <h2>Initial Assessment</h2>
                    <div class="content">
                        The initial hypothesis was Myelinating Schwann Cells, supported by the presence of PLP1, SOX10, and FOXD3. However, the presence of markers associated with broader neuron-glia interactions (L1CAM, NRXN1, CADM2, PTPRZ1) and other glial markers (GFRA2, CHADL, CHST9, GJC3), along with the large intestine context, suggested potential alternative glial subtypes or mixed populations.
                    </div>
                </section>
        
                <section>
                    <h2>Iteration 1</h2>
                    
                    <div class="sub-section">
                        <h3>Hypotheses</h3>
                        <div class="content">
                            <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To confirm the myelinating phenotype and distinguish from other glial cells by examining canonical myelin markers and markers of other glial types.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To differentiate from Non-myelinating (Remak) Schwann cells by checking for markers typically higher in non-myelinating cells and other associated markers.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To rule out potential contamination or doublets with other common stromal or epithelial cell types present in the large intestine.</div></div>
                        </div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Genes Checked</h3>
                        <div class="gene-list"><span class="gene-badge">MPZ</span><span class="gene-badge">PMP22</span><span class="gene-badge">EGR2</span><span class="gene-badge">KROX20</span><span class="gene-badge">S100B</span><span class="gene-badge">GFAP</span><span class="gene-badge">AQP4</span><span class="gene-badge">NGFR</span><span class="gene-badge">CDH19</span><span class="gene-badge">LPL</span><span class="gene-badge">SFRP5</span><span class="gene-badge">MEGF10</span><span class="gene-badge">CDH2</span><span class="gene-badge">TENM3</span><span class="gene-badge">PECAM1</span><span class="gene-badge">CD34</span><span class="gene-badge">PDGFRA</span><span class="gene-badge">COL1A1</span><span class="gene-badge">ACTA2</span><span class="gene-badge">EPCAM</span><span class="gene-badge">CDH1</span></div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Key Findings</h3>
                        <div class="content">
                            No information available
                        </div>
                    </div>
                </section>
            
                <section>
                    <h2>Iteration 2</h2>
                    
                    <div class="sub-section">
                        <h3>Hypotheses</h3>
                        <div class="content">
                            <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To further solidify the Schwann cell identity and assess consistency with the initial annotation by re-examining key supporting markers and neuron-glia interaction genes.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To investigate less canonical markers from the top list (GFRA2, CHADL, CHST9, GJC3, FAM19A5, FGFBP2, LINC01436) that might point towards specific subtypes or states.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To rule out minor contaminating populations or indicate a potential link to neural crest-derived lineages beyond mature Schwann cells by examining markers like SOX2, CRTAC1, CHL1, ZNF536, GRIK3, TUBB2B, and CMTM5.</div></div>
                        </div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Genes Checked</h3>
                        <div class="gene-list"><span class="gene-badge">SOX10</span><span class="gene-badge">PLP1</span><span class="gene-badge">FOXD3</span><span class="gene-badge">NRXN1</span><span class="gene-badge">L1CAM</span><span class="gene-badge">CADM2</span><span class="gene-badge">PTPRZ1</span><span class="gene-badge">GFRA2</span><span class="gene-badge">CHADL</span><span class="gene-badge">CHST9</span><span class="gene-badge">GJC3</span><span class="gene-badge">FAM19A5</span><span class="gene-badge">FGFBP2</span><span class="gene-badge">LINC01436</span><span class="gene-badge">SOX2</span><span class="gene-badge">CRTAC1</span><span class="gene-badge">CHL1</span><span class="gene-badge">ZNF536</span><span class="gene-badge">GRIK3</span><span class="gene-badge">TUBB2B</span><span class="gene-badge">CMTM5</span></div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Key Findings</h3>
                        <div class="content">
                            No information available
                        </div>
                    </div>
                </section>
            
                <section>
                    <h2>Iteration 3</h2>
                    
                    <div class="sub-section">
                        <h3>Hypotheses</h3>
                        <div class="content">
                            <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To further distinguish between myelinating and non-myelinating populations by examining markers like PRX (myelinating enriched) and NCAM1, and re-evaluating NGFR co-expression with myelin markers. Also, to re-confirm the absence of other glial and stromal contamination markers.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To understand if highly expressed markers like CDH19, LPL, SFRP5, MEGF10, CDH2, TENM3, and FAM19A5 define a specific functional state or subtype by examining their co-expression with myelinating and non-myelinating markers.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To clarify the significance of SOX2, CRTAC1, CHL1, GRIK3, TUBB2B, CMTM5, and ZNF536 expression by analyzing their co-expression with Schwann cell markers and markers of other neural lineages.</div></div>
                        </div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Genes Checked</h3>
                        <div class="gene-list"><span class="gene-badge">PRX</span><span class="gene-badge">NCAM1</span><span class="gene-badge">CD271</span><span class="gene-badge">GFAP</span><span class="gene-badge">AQP4</span><span class="gene-badge">PDGFRA</span><span class="gene-badge">COL1A1</span><span class="gene-badge">CDH19</span><span class="gene-badge">LPL</span><span class="gene-badge">SFRP5</span><span class="gene-badge">MEGF10</span><span class="gene-badge">CDH2</span><span class="gene-badge">TENM3</span><span class="gene-badge">FAM19A5</span><span class="gene-badge">SOX2</span><span class="gene-badge">CRTAC1</span><span class="gene-badge">CHL1</span><span class="gene-badge">GRIK3</span><span class="gene-badge">TUBB2B</span><span class="gene-badge">CMTM5</span><span class="gene-badge">ZNF536</span></div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Key Findings</h3>
                        <div class="content">
                            No information available
                        </div>
                    </div>
                </section>
            
                <section>
                    <h2>Iteration 4</h2>
                    
                    <div class="sub-section">
                        <h3>Hypotheses</h3>
                        <div class="content">
                            <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To definitively assess the proportion of myelinating and non-myelinating cells by examining the co-expression patterns of canonical myelin markers (PLP1, MPZ, PMP22, EGR2) with the non-myelinating marker NGFR, using SOX10 and S100B as controls.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To understand if the highly expressed markers like CDH19, LPL, SFRP5, MEGF10, CDH2, TENM3, and FAM19A5 are associated with a specific subtype or represent a general characteristic of enteric glial cells by analyzing their co-expression with myelinating and non-myelinating markers.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To clarify the significance of SOX2, CRTAC1, CHL1, GRIK3, TUBB2B, CMTM5, and ZNF536 expression by examining their co-expression with both myelinating and non-myelinating markers, as well as with known markers of neural progenitors or other enteric nervous system components.</div></div>
                        </div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Genes Checked</h3>
                        <div class="gene-list"><span class="gene-badge">PLP1</span><span class="gene-badge">MPZ</span><span class="gene-badge">PMP22</span><span class="gene-badge">EGR2</span><span class="gene-badge">NGFR</span><span class="gene-badge">SOX10</span><span class="gene-badge">S100B</span><span class="gene-badge">CDH19</span><span class="gene-badge">LPL</span><span class="gene-badge">SFRP5</span><span class="gene-badge">MEGF10</span><span class="gene-badge">CDH2</span><span class="gene-badge">TENM3</span><span class="gene-badge">FAM19A5</span><span class="gene-badge">SOX2</span><span class="gene-badge">CRTAC1</span><span class="gene-badge">CHL1</span><span class="gene-badge">GRIK3</span><span class="gene-badge">TUBB2B</span><span class="gene-badge">CMTM5</span><span class="gene-badge">ZNF536</span></div>
                    </div>
                    
                    <div class="sub-section">
                        <h3>Key Findings</h3>
                        <div class="content">
                            No information available
                        </div>
                    </div>
                </section>
            
                <section class="final-annotation">
                    <h2>Final Annotation</h2>
                    <div class="content">
                        The final cell type is **Enteric Glial Cells (Mixed Myelinating and Non-myelinating)**. The confidence level is high. Key supporting evidence includes the presence of pan-glial markers (SOX10, S100B), myelinating markers (PLP1, MPZ, PMP22, EGR2), and the non-myelinating marker (NGFR), with co-expression patterns indicating heterogeneity.
                    </div>
                </section>
        
                <section>
                    <h2>Key Marker Genes</h2>
                    <div class="content">
                        Pan-Glial Markers: SOX10, S100B, NCAM1
Myelinating Schwann Cell Markers: PLP1, MPZ, PMP22, EGR2, PRX
Non-myelinating Schwann Cell Markers: NGFR
Neuron-Glia Interaction Markers: NRXN1, L1CAM, CADM2, PTPRZ1
Other Highly Expressed/Potential Subtype Markers: CDH19, LPL, SFRP5, MEGF10, CDH2, TENM3, FAM19A5, GFRA2, CHADL, CHST9, GJC3, FGFBP2, LINC01436
Markers Indicating Heterogeneity/Transitional States: SOX2, CRTAC1, CHL1, GRIK3, TUBB2B, CMTM5, ZNF536
                    </div>
                </section>
        
                <section>
                    <h2>Recommendations</h2>
                    <div class="content">
                        Further analysis at the single-cell level, such as subclustering or trajectory inference, is recommended to fully characterize the heterogeneity, resolve distinct subpopulations (myelinating vs. non-myelinating), and identify potential transitional states within this cluster.
                    </div>
                </section>
            
            </div>
        </body>
        </html>
        